title: Adjuvant therapy in the treatment of non-small-cell lung cancer.
abstract: Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.
authors.affiliation: Section of Medical Oncology, Department of Medicine, University of Wisconsin Comprehensive Cancer Center, Madison 53792, USA.
authors.forename: Anne M
authors.initials: AM
authors.lastname: Traynor
authors.forename: Joan H
authors.initials: JH
authors.lastname: Schiller